Below is a list of Parkinson's Disease clinical trials from the clinical trials database at Mayo Clinic.
Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.
Effects of Coenzyme Q10 in Parkinson's Disease (QE3)
The purpose of this study is to find out whether Coenzyme Q10 (CoQ) can slow the progression of early Parkinson's Disease. CoQ is a vitamin-like substance that is naturally made in the body.
Read more
Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)
A study to test the therapeutic benefit of the compound PYM50028, versus placebo, in treating early-stage Parkinson's disease. Therapeutic benefit will be assessed using the Unified Parkinson's Disease Rating Scale (UPDRS). It is hypothesised that PYM50028 will be safe and well tolerated in this study and demonstrate therapeutic benefit in this patient population.
Read more
Find Mayo Clinic on